Takeda Pharmaceutical Co ADR (NYSE: TAK) is -2.42% lower on its value in year-to-date trading and has touched a low of $12.57 and a high of $15.08 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TAK stock was last observed hovering at around $12.89 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $12.92, the stock is -1.57% and -3.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.38 million and changing 0.23% at the moment leaves the stock -5.57% off its SMA200. TAK registered -12.64% loss for a year compared to 6-month loss of -5.42%. The firm has a 50-day simple moving average (SMA 50) of $13.3784 and a 200-day simple moving average (SMA200) of $13.6858.
The stock witnessed a -0.69% gain in the last 1 month and extending the period to 3 months gives it a -8.69%, and is -1.37% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.07% over the week and 1.00% over the month.
Takeda Pharmaceutical Co ADR (TAK) has around 49281 employees, a market worth around $40.96B and $30.22B in sales. Current P/E ratio is 21.43 and Fwd P/E is 28.79. Profit margin for the company is 6.36%. Distance from 52-week low is 2.74% and -14.32% from its 52-week high. The company has generated returns on investments over the last 12 months (2.42%).
with sales reaching $1.13T over the same period.The EPS is expected to shrink by -12.76% this year, but quarterly earnings will post 659.64% year-over-year. Quarterly sales are estimated to grow 1.89% in year-over-year returns.
355.0 institutions hold shares in Takeda Pharmaceutical Co ADR (TAK), with institutional investors hold 2.45% of the company’s shares. The shares outstanding are 3.17B, and float is at 3.17B with Short Float at 0.15%. Institutions hold 2.45% of the Float.
The top institutional shareholder in the company is CAPITAL RESEARCH GLOBAL INVESTORS with over 13.13 million shares valued at $169.86 million. The investor’s holdings represent 0.8366 of the TAK Shares outstanding. As of 2024-06-30, the second largest holder is MONDRIAN INVESTMENT PARTNERS LTD with 7.74 million shares valued at $108.34 million to account for 0.4932 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 4.99 million shares representing 0.3178 and valued at over $64.53 million, while MILLENNIUM MANAGEMENT LLC holds 0.277 of the shares totaling 4.35 million with a market value of $56.24 million.
